These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 11215774)

  • 21. A neuroblastoma cell line derived from a case detected through a mass screening system in Japan: a case report including the biologic and phenotypic characteristics of the cell line.
    Hiraiwa H; Hamazaki M; Takata A; Kikuchi H; Hata J
    Cancer; 1997 May; 79(10):2036-44. PubMed ID: 9149033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proliferation marker KI-S5 discriminates between favorable and adverse prognosis in advanced stages of neuroblastoma with and without MYCN amplification.
    Krams M; Hero B; Berthold F; Parwaresch R; Harms D; Rudolph P
    Cancer; 2002 Feb; 94(3):854-61. PubMed ID: 11857322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retrospective study on amplification of N-myc and c-myc genes in pediatric solid tumors and its association with prognosis and tumor differentiation.
    Tsuda H; Shimosato Y; Upton MP; Yokota J; Terada M; Ohira M; Sugimura T; Hirohashi S
    Lab Invest; 1988 Sep; 59(3):321-7. PubMed ID: 3411933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inverse relationship between trk expression and N-myc amplification in human neuroblastomas.
    Nakagawara A; Arima M; Azar CG; Scavarda NJ; Brodeur GM
    Cancer Res; 1992 Mar; 52(5):1364-8. PubMed ID: 1737399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of the prognostic factors relating to better clinical outcome in ganglioneuroblastoma.
    Kubota M; Suita S; Tajiri T; Shono K; Fujii Y
    J Pediatr Surg; 2000 Jan; 35(1):92-5. PubMed ID: 10646782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of B-myb in neuroblastoma tumors is a poor prognostic factor independent from MYCN amplification.
    Raschellà G; Cesi V; Amendola R; Negroni A; Tanno B; Altavista P; Tonini GP; De Bernardi B; Calabretta B
    Cancer Res; 1999 Jul; 59(14):3365-8. PubMed ID: 10416595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biology of neuroblastomas in Japan found by screening.
    Hayashi Y; Hanada R; Yamamoto K
    Am J Pediatr Hematol Oncol; 1992 Nov; 14(4):342-7. PubMed ID: 1456401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a Pediatric Oncology Group study.
    George RE; London WB; Cohn SL; Maris JM; Kretschmar C; Diller L; Brodeur GM; Castleberry RP; Look AT
    J Clin Oncol; 2005 Sep; 23(27):6466-73. PubMed ID: 16116152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Neuroblastoma in children under than 1 year of age].
    Castel Sánchez V; Melero Moreno C; García-Miguel García-Rosados P; Navajas Gutiérrez A; Ruiz Jiménez JI; Navarro Fos S; Garín Valle JC; Galbe Sada M
    An Esp Pediatr; 1997 Dec; 47(6):584-90. PubMed ID: 9575117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroblastoma in the first year of life: clinical and biologic factors influencing outcome.
    Grosfeld JL; Rescorla FJ; West KW; Goldman J
    Semin Pediatr Surg; 1993 Feb; 2(1):37-46. PubMed ID: 8062021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prognostic factors in neuroblastoma in children].
    Blinov VM; Bukhny AF; Izrail'skaia MA; Dzhalalov KD
    Vopr Onkol; 1984; 30(5):21-31. PubMed ID: 6730411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Favorable outcome of triploid neuroblastomas: a contribution to the special oncogenesis of neuroblastoma.
    Spitz R; Betts DR; Simon T; Boensch M; Oestreich J; Niggli FK; Ernestus K; Berthold F; Hero B
    Cancer Genet Cytogenet; 2006 May; 167(1):51-6. PubMed ID: 16682287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Risk and benefits of surgical interventions in localized neuroblastoma--experiences from cooperative studies in Germany].
    Hero B; Holschneider AM; Berthold F
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():1062-9. PubMed ID: 9101782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resection of neurogenic tumors in children: is thoracoscopy superior to thoracotomy?
    Petty JK; Bensard DD; Partrick DA; Hendrickson RJ; Albano EA; Karrer FM
    J Am Coll Surg; 2006 Nov; 203(5):699-703. PubMed ID: 17084332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The high level of hCDC10 gene expression in neuroblastoma may be associated with favorable characteristics of the tumor.
    Nagata T; Takahashi Y; Asai S; Ishii Y; Mugishima H; Suzuki T; Chin M; Harada K; Koshinaga S; Ishikawa K
    J Surg Res; 2000 Aug; 92(2):267-75. PubMed ID: 10896833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reevaluation of trkA expression as a biological marker of neuroblastoma by high-sensitivity expression analysis--a study of 106 primary neuroblastomas treated in a single institute.
    Hishiki T; Saito T; Terui K; Sato Y; Takenouchi A; Yahata E; Ono S; Nakagawara A; Kamijo T; Nakamura Y; Matsunaga T; Yoshida H
    J Pediatr Surg; 2010 Dec; 45(12):2293-8. PubMed ID: 21129533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgical treatment of neuroblastomas in infants under 12 months of age.
    Ikeda H; Suzuki N; Takahashi A; Kuroiwa M; Nagashima K; Tsuchida Y; Matsuyama S
    J Pediatr Surg; 1998 Aug; 33(8):1246-50. PubMed ID: 9721996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [N-myc gene copies in children with neuroblastoma and its clinical significance].
    Ma XL; Gong LP; Zhou CJ; Zhang DW; Jin M; Wang HM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1447-51. PubMed ID: 23257451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgical treatment for pediatric mediastinal neurogenic tumors.
    Fraga JC; Aydogdu B; Aufieri R; Silva GV; Schopf L; Takamatu E; Brunetto A; Kiely E; Pierro A
    Ann Thorac Surg; 2010 Aug; 90(2):413-8. PubMed ID: 20667322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical relevance of CD44 cell-surface expression and N-myc gene amplification in a multicentric analysis of 121 pediatric neuroblastomas.
    Combaret V; Gross N; Lasset C; Frappaz D; Peruisseau G; Philip T; Beck D; Favrot MC
    J Clin Oncol; 1996 Jan; 14(1):25-34. PubMed ID: 8558206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.